E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers C > Headlines for CuraGen Corp. > News item
Published on 6/22/2009 in the Prospect News Special Situations Daily.

CuraGen investor DellaCamera sells shares, cuts ownership to 4.5%

By Lisa Kerner

Charlotte, N.C., June 22 - Investors led by DellaCamera Capital Master Fund, Ltd. sold 1,412,500 shares of CuraGen Corp. between June 1 and June 19 priced from $1.35 to $1.42 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Monday.

The investor and its affiliates beneficially own 2,562,546 shares, or 4.5%, of the Branford, Conn.-based biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.